| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |